Home › Companies › Korro Bio, Inc. › 2025-2026

Korro Bio, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Korro Bio, Inc.’s Form 8-K, filed June 11, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 4Ballot items
  • 124Asset managers
  • 494Fund votes
  • June 10, 2026Meeting date

Results at a glance

Meeting of June 10, 2026: 4 items on Korro Bio, Inc.’s Form 8-K, filed June 11, 2026: 2 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore Korro Bio, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Korro Bio, Inc.

These tallies are Korro Bio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Korro Bio, Inc. — official shareholder meeting results, meeting held June 10, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Nessan Bermingham 7,468,003---- 1,576,6601,875,955 83%Elected—
Elect Director: Rachel Meyers 7,368,284---- 1,676,3791,875,955 81%Elected—
Proposal 2: Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive officers. 9,009,73927,9886,936 --1,875,955 99.6%Approved—
Proposal 3: Korro's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026. 10,917,6212,738259 --0 99.9%Approved—

Source: Korro Bio, Inc., Form 8-K, filed with the SEC on June 11, 2026 — read the filing on EDGAR.

How asset managers voted at the Korro Bio, Inc. 2025-2026 meeting

Each item below shows how the 124 asset managers that disclosed a Korro Bio, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Nessan Bermingham

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%WITHHELD
FOR: 7,468,003WITHHELD: 1,576,660
Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: Election of two Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Nessan Bermingham

Korro Bio, Inc.’s own tally for this item (“Elect Director: Nessan Bermingham”): 7,468,003 for, 1,576,660 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “1) Korro's stockholders elected each of Nessan Bermingham and Rachel Meyers as Class I directors, each for a three-year term ending at the annual meeting of stockholders to be held in 2029 and each until his or her respective successor has been duly elected and qualified or until his or her earlier…”
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 484,351 for, 298,983 withheld, 3 abstained.

FORWITHHOLD
FOR: 484,351ABSTAIN: 3WITHHOLD: 298,983
Largest asset managers voting on “Election of two Class I directors, nominated by our board of directors, each to serve for a three-year term ex” at Korro Bio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard322,7250 30For
Fidelity126,2170 032,866Mixed
BlackRock00 0155,153Withhold
RBB FUND, INC.00 062,855Withhold
Charles Schwab13,3780 00For
QUANTITATIVE MASTER SERIES LLC00 010,341Withhold
TIAA00 08,283Withhold
Dimensional00 07,762Withhold
Equitable4,7600 02,026Mixed
T. Rowe Price00 05,878Withhold
Lincoln Financial4,5000 00For
Northern Trust4,3910 00For
Goldman Sachs3,2900 00For
Global X3,2420 00For
AIG/SunAmerica00 03,058Withhold
Bridge Builder Trust00 02,830Withhold
Pacific Life00 02,438Withhold
John Hancock00 01,998Withhold
Nationwide2980 0704Mixed
DWS00 0966Withhold
ProShares00 0888Withhold
State Street6200 00For
Calvert00 0598Withhold
Venerable Variable Insurance Trust5490 00For
Principal00 0245Withhold

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

2. Elect Director: Rachel Meyers

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD
FOR: 7,368,284WITHHELD: 1,676,379
Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: Election of two Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Rachel Meyers

Korro Bio, Inc.’s own tally for this item (“Elect Director: Rachel Meyers”): 7,368,284 for, 1,676,379 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “1) Korro's stockholders elected each of Nessan Bermingham and Rachel Meyers as Class I directors, each for a three-year term ending at the annual meeting of stockholders to be held in 2029 and each until his or her respective successor has been duly elected and qualified or until his or her earlier…”
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 516,773 for, 266,561 withheld, 3 abstained.

FORWITHHOLD
FOR: 516,773ABSTAIN: 3WITHHOLD: 266,561
Largest asset managers voting on “Election of two Class I directors, nominated by our board of directors, each to serve for a three-year term ex” at Korro Bio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard322,7250 30For
Fidelity159,0830 00For
BlackRock00 0155,153Withhold
RBB FUND, INC.00 062,855Withhold
Charles Schwab13,3780 00For
QUANTITATIVE MASTER SERIES LLC00 010,341Withhold
TIAA8,2830 00For
Dimensional00 07,762Withhold
Equitable00 06,786Withhold
T. Rowe Price5,8780 00For
Lincoln Financial00 04,500Withhold
Northern Trust00 04,391Withhold
Goldman Sachs3,2900 00For
Global X3,2420 00For
AIG/SunAmerica00 03,058Withhold
Bridge Builder Trust00 02,830Withhold
Pacific Life00 02,438Withhold
John Hancock00 01,998Withhold
Nationwide2980 0704Mixed
DWS00 0966Withhold
ProShares00 0888Withhold
State Street00 0620Withhold
Calvert00 0598Withhold
Venerable Variable Insurance Trust5490 00For
Principal00 0245Withhold

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

3. Proposal 2: Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

99.6% Approved · of votes cast

FOR 99.6%
FOR: 9,009,739AGAINST: 27,988
Details: description as filed, official tally, votes by 124 asset managers

Description as filed by funds: Non-Binding advisory vote to approve the compensation of our named executive officers;

Korro Bio, Inc.’s own tally for this item (“Proposal 2: Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive officers.”): 9,009,739 for, 27,988 against — passed, per its Form 8-K filed June 11, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “2) Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive officers.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 31 asset managers voting on “Non-Binding advisory vote to approve the compensation of our named executive officers;” at Korro Bio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard322,7280 00For
Fidelity159,0830 00For
BlackRock155,1530 00For
RBB FUND, INC.62,8550 00For
Charles Schwab13,3780 00For
QUANTITATIVE MASTER SERIES LLC10,3410 00For
TIAA8,2830 00For
Dimensional07,762 00Against
Equitable6,7860 00For
T. Rowe Price5,8780 00For
Lincoln Financial4,5000 00For
Northern Trust4,3910 00For
Goldman Sachs3,2900 00For
Global X3,2420 00For
AIG/SunAmerica3,0580 00For
Bridge Builder Trust2,8300 00For
Pacific Life2,4380 00For
John Hancock1,9980 00For
Nationwide1,0020 00For
DWS9660 00For
ProShares8880 00For
State Street6200 00For
Calvert5980 00For
Venerable Variable Insurance Trust5490 00For
Principal2450 00For

Fund voting reports, all 31 managers: 775,551 for, 7,786 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 102 asset managers voting on “Non-Binding advisory vote to approve the compensation of our named executive officers;” at Korro Bio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Lynx1 Capital Management LP1,538,2960 00For
NEA Management Company, LLC1,299,2300 00For
Atlas Venture Life Science Advisors, LLC1,137,1490 00For
Venrock Adviser, LLC1,009,5000 00For
DRIEHAUS CAPITAL MANAGEMENT LLC450,0450 00For
Siren, L.L.C.347,7180 00For
Nantahala Capital Management, LLC299,0360 00For
Point72276,8310 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.228,4000 00For
AQR158,0010 00For
Affinity Asset Advisors, LLC156,2500 00For
GEODE CAPITAL MANAGEMENT, LLC150,0510 00For
BALYASNY ASSET MANAGEMENT L.P.134,8200 00For
State Street114,271270 00For
BlackRock71,33818 00For
Cornerstone National Bank & Trust Co56,6740 00For
Two Sigma37,7170 00For
Fidelity36,9280 00For
Northern Trust31,7300 00For
MARSHALL WACE, LLP30,8520 00For
MELLON INVESTMENTS Corp27,2550 00For
Vanguard23,1610 00For
T. Rowe Price14,1680 00For
Charles Schwab13,3940 00For
Nuveen12,7230 00For

Institutional-manager reports, all 102 managers: 7,729,105 for, 9,684 against, 2,164 abstained. Showing the 25 largest; see all in the interactive database.

4. Proposal 3: Korro's stockholders ratified the selection of Ernst & Young LLP as its independent registered public…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 10,917,621AGAINST: 2,738
Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;

Korro Bio, Inc.’s own tally for this item (“Proposal 3: Korro's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026.”): 10,917,621 for, 2,738 against — passed, per its Form 8-K filed June 11, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “3) Korro's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 783,337 for.

FOR
FOR: 783,337
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for ” at Korro Bio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard322,7280 00For
Fidelity159,0830 00For
BlackRock155,1530 00For
RBB FUND, INC.62,8550 00For
Charles Schwab13,3780 00For
QUANTITATIVE MASTER SERIES LLC10,3410 00For
TIAA8,2830 00For
Dimensional7,7620 00For
Equitable6,7860 00For
T. Rowe Price5,8780 00For
Lincoln Financial4,5000 00For
Northern Trust4,3910 00For
Goldman Sachs3,2900 00For
Global X3,2420 00For
AIG/SunAmerica3,0580 00For
Bridge Builder Trust2,8300 00For
Pacific Life2,4380 00For
John Hancock1,9980 00For
Nationwide1,0020 00For
DWS9660 00For
ProShares8880 00For
State Street6200 00For
Calvert5980 00For
Venerable Variable Insurance Trust5490 00For
Principal2450 00For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

Largest Korro Bio, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 14,422,571 shares outstanding at the time of that meeting.

Fund voting reports: top Korro Bio, Inc. shareholders by shares voted on “Non-Binding advisory vote to approve the compensation of our named executive officers;”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 2.24%
2Fidelity 1.10%
3BlackRock 1.08%
4RBB FUND, INC. 0.44%
5Charles Schwab 0.09%
6QUANTITATIVE MASTER SERIES LLC 0.07%
7TIAA 0.06%
8Dimensional 0.05%
9Equitable 0.05%
10T. Rowe Price 0.04%
Institutional-manager reports: top Korro Bio, Inc. shareholders by shares voted on “Non-Binding advisory vote to approve the compensation of our named executive officers;”, 2025-2026
#Asset manager % of shares outstanding
1Lynx1 Capital Management LP 10.67%
2NEA Management Company, LLC 9.01%
3Atlas Venture Life Science Advisors, LLC 7.88%
4Venrock Adviser, LLC 7.00%
5DRIEHAUS CAPITAL MANAGEMENT LLC 3.12%
6Siren, L.L.C. 2.41%
7Nantahala Capital Management, LLC 2.07%
8Point72 1.92%
9ADAGE CAPITAL PARTNERS GP, L.L.C. 1.58%
10AQR 1.10%

Reported Korro Bio, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Korro Bio, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Lynx1 Capital Management LP 10.67% 13G
Venrock Healthcare Capital Partners III, L.P. 10.32% 13G
New Enterprise Associates 17, L.P. 9.95% 13D
BALYASNY ASSET MANAGEMENT L.P. 6.60% 13G
Steven A. Cohen 5.66% 13G
Atlas Venture Fund XI, L.P. 4.90% 13D
Vanguard Group 3.39% 13F
BlackRock 3.19% 13F
Point72 Biotech Private Investments, LLC 1.92% 13G
Citadel Advisors 1.87% 13F

Percentages above are of 14,422,571 shares outstanding, as reported by Korro Bio, Inc. on its Form 10-Q dated May 4, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Korro Bio, Inc.’s 10-Q dated May 4, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At Korro Bio, Inc.'s shareholder meeting held June 10, 2026, in the 2025-2026 proxy season, 124 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 494 separate fund positions. On the most widely held item on that ballot — Non-Binding advisory vote to approve the compensation of our named executive officers; — Korro Bio, Inc.'s filing reports the proposal as approved, with 99.6% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Korro Bio, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 11, 2026.

Korro Bio, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.